OQS
TIL icon

Occudo Quantitative Strategies’s Instil Bio TIL Stock Holding History

Occudo Quantitative Strategies’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-780
Closed -$8.6K – 1306
2023
Q2 		$8.6K Hold
780
– – ﹤0.01% 973
2023
Q1 		$10.3K Sell
780
-91
-10% -$1.34K ﹤0.01% 873
2022
Q4 		$11K Buy
+871
New +$43K ﹤0.01% 915
2022
Q3 		– Sell
-2,187
Closed -$202K – 1414
2022
Q2 		$202K Buy
+2,187
New +$310K 0.02% 911

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Occudo Quantitative Strategies's TIL Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 780 shares — an estimated $8.6K sold.

Occudo Quantitative Strategies first reported a position in TIL in Q2 2022 and held it in 4 quarters. The position peaked at $202K in Q2 2022. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 780 Instil Bio shares in Q3 2023, an estimated $8.6K.
  • Occudo Quantitative Strategies first reported a position in Instil Bio in Q2 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Instil Bio position peaked at $202K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.